grant

DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES

Organization INIMMUNE CORPORATIONLocation MISSOULA, UNITED STATESPosted 30 Sept 2023Deadline 29 Sept 2028
NIHUS FederalResearch GrantFY2024AdjuvantAgonistAntibodiesAntigensBacterial VaccinesBacterinChemistryCollaborationsContracting OpportunitiesContractorContractsCyclic GMPDevelopmentDrug KineticsExcretory functionExhibitsFerretsFormulationGenerationsGuanosine Cyclic MonophosphateH1N1H1N1 VirusH3N2H3N2 VirusHeadHomolog of Drosophila TOLLImmune responseImmunological responseInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza BInfluenza B VirusInfluenza VaccinesInfluenza Viruses Type BIntermediary MetabolismLeadMetabolic ProcessesMetabolismModelingOrthomyxoviruses Type BPb elementPharmacokineticsProteinsQS 21QS-21 AdjuvantQS21RecombinantsSafetySaponinsStimulon QS-21 AdjuvantSystemT-CellsT-LymphocyteTLR4TLR4 geneToll HomologueToxicologyVaccine AdjuvantVaccinesViral VaccinesabsorptioncGMPdevelopmentalexcretionfluflu vaccineflu virus vaccineheavy metal Pbheavy metal leadhost responseimmune system responseimmunogenimmunogenicityimmunoresponseinfluenza virus vaccinemanufacturenovelpre-clinicalpreclinicalscale upseasonal fluseasonal influenzathymus derived lymphocytetoll-like receptor 4vaccine against fluvaccine against influenza
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Inimmune is developing a second generation synthetic AS01-like adjuvant system (termed SAS), by partnering our novel fully synthetic TLR4 agonist INI-2002, with a semi-synthetic saponin for use in vaccines. Pre-clinically, SAS has demonstrated excellent antibody and T-cell immune responses when paired with a split flu antigen. This versatile…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →